MPLT

MapLight Therapeutics, Inc.

MPLTNASDAQ

MapLight Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher A. Kroeger, with a market cap of $712.4M.

CEOChristopher A. Kroeger
Market Cap$712.4M
Biotechnology
Healthcare

Next Earnings

Upcoming earnings announcement for MapLight Therapeutics, Inc.

Date
Saturday, February 28, 2026 (in 3 weeks)
Timing
Before Market Open (3:30 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$1.02

Earnings History

Past 1 earnings report for MapLight Therapeutics, Inc.

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Dec 4, 2025Q3 2025
-$37.18Est: -$1.36
-2633.8%
-
SEC10-Q

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.